פלוסלמר אס.קיי. 50250 מקג इसराइल - हिब्रू - Ministry of Health

פלוסלמר אס.קיי. 50250 מקג

k.s.kim international (sk- pharma) ltd., israel - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - salmeterol as xinafoate 50 mcg; fluticasone propionate 250 mcg - salmeterol and other drugs for obstructive airway diseases

פלוסלמר אס.קיי. 50500 מקג इसराइल - हिब्रू - Ministry of Health

פלוסלמר אס.קיי. 50500 מקג

k.s.kim international (sk- pharma) ltd., israel - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - salmeterol as xinafoate 50 mcg; fluticasone propionate 500 mcg - salmeterol and other drugs for obstructive airway diseases

דפאלפט סירופ इसराइल - हिब्रू - Ministry of Health

דפאלפט סירופ

cts chemical industries ltd, israel - valproic acid as sodium - סירופ - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

דואוטרב इसराइल - हिब्रू - Ministry of Health

דואוטרב

novartis israel ltd - timolol as maleate; travoprost - תמיסה לעין - travoprost 40 mcg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intraocular pressure (iop) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

אזרגה इसराइल - हिब्रू - Ministry of Health

אזרגה

novartis israel ltd - brinzolamide; timolol as maleate - תרחיף לעין - brinzolamide 10 mg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intra-ocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction.

טרבתן इसराइल - हिब्रू - Ministry of Health

טרבתן

novartis israel ltd - travoprost - תמיסה לעין - travoprost 0.004 %w/v - travoprost - travoprost - for the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other iop lowering medications or insufficiently responsive to another iop lowering medication.

קוסופט इसराइल - हिब्रू - Ministry of Health

קוסופט

rafa laboratories ltd - dorzolamide as hydrochloride; timolol as maleate - תמיסה לעין - dorzolamide as hydrochloride 20 mg/ml; timolol as maleate 5 mg/ml - timolol - carbonic anhydrase inhibitors - for the treatment of elevated intraocular pressure (iop ) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma when concomitant therapy is appropriate.

פרזיסטה 75 מג इसराइल - हिब्रू - Ministry of Health

פרזיסטה 75 מג

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 75 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini

פרזיסטה 150 מג इसराइल - हिब्रू - Ministry of Health

פרזיסטה 150 מג

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 150 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini

גאמונקס  - סי इसराइल - हिब्रू - Ministry of Health

גאמונקס - סי

padagis israel agencies ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).